The entity is in discussions regarding provision of funds to the entity.
The entity anticipates these discussions will enable the Company to fund its operations.
The partnership Agreement with Akira provides for the entity and its respective subsidiaries to receive reimbursement of its development costs and other project.
Only another quarter of funding left in the kitty
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
The entity is in discussions regarding provision of funds to the...
Featured News
Add KPO (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.39M |
Open | High | Low | Value | Volume |
1.0¢ | 1.1¢ | 1.0¢ | $2.005K | 192.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 2040039 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 1888787 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 2040039 | 0.010 |
3 | 1187272 | 0.009 |
1 | 111111 | 0.008 |
3 | 2575000 | 0.007 |
1 | 55000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 1888787 | 3 |
0.012 | 2660000 | 5 |
0.013 | 517918 | 2 |
0.014 | 1119269 | 3 |
0.015 | 1015000 | 2 |
Last trade - 15.58pm 15/11/2024 (20 minute delay) ? |
Featured News
KPO (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online